Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
National Health & Medical Research Council (NHMRC)
Scientific Title
A Randomised Phase II Study of NivolUmab and TeMozolomide vs Temozolomide alone in newly diagnosed Elderly patients with Glioblastoma (NUTMEG) to analyse overall survival.